Overview
No overview information available.
Indication
⑴非髓性恶性肿瘤患者在接受会发生有临床意义发热性中性粒细胞减少的抑制骨髓的抗肿瘤药治疗时，使用本品可降低发热性中性粒细胞减少引起的感染发生率。 ⑵本品不用于造血干细胞移植的外周血祖细胞的动员。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/07/25 | Phase 3 | Recruiting | The Affiliated People's Hospital of Ningbo University | ||
2023/09/07 | Phase 4 | Recruiting | Chongqing University Cancer Hospital | ||
2023/08/01 | Early Phase 1 | Not yet recruiting | Zhongnan Hospital | ||
2023/04/28 | Not Applicable | Not yet recruiting | Ou Bai, MD/PHD | ||
2022/09/10 | Not Applicable | Recruiting | The Affiliated People's Hospital of Ningbo University | ||
2022/09/07 | Not Applicable | Recruiting | |||
2022/08/22 | Not Applicable | Recruiting | The Affiliated People's Hospital of Ningbo University | ||
2022/06/08 | Phase 4 | Not yet recruiting | Ning Huang | ||
2022/02/03 | Phase 1 | UNKNOWN | Sun Yat-sen University | ||
2021/12/14 | Not Applicable | UNKNOWN | Sun Yat-sen University |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Pegylated Human Granulocyte Colony-stimulating Factor Injection | 国药准字S20250005 | 生物制品 | 注射剂 | 1/14/2025 | |
| Pegylated Human Granulocyte Colony-stimulating Factor Injection | 国药准字S20230049 | 生物制品 | 注射剂 | 9/19/2023 | |
| Pegylated Human Granulocyte Colony-stimulating Factor Injection | 国药准字S20110014 | 生物制品 | 注射剂 | 3/3/2021 | |
| Pegylated Human Granulocyte Colony-stimulating Factor Injection | 国药准字S20210011 | 生物制品 | 注射剂 | 4/30/2021 | |
| Pegylated Human Granulocyte Colony-stimulating Factor Injection | 国药准字S20150013 | 生物制品 | 注射剂 | 4/24/2020 | |
| Pegylated Human Granulocyte Colony-stimulating Factor Injection | 国药准字S20258007 | 生物制品 | 注射剂 | 5/19/2025 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.